[HTML][HTML] High potential of technology to face new respiratory viruses: mechanical ventilation devices for effective healthcare to next pandemic emergencies

M Coccia - Technology in Society, 2023 - Elsevier
Some countries in the presence of unforeseen Coronavirus Disease 2019 (COVID-19)
pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have …

Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19

J Gambardella, U Kansakar, C Sardu, V Messina… - … of Pharmacology and …, 2023 - ASPET
We hypothesized that exosomal microRNAs could be implied in the pathogenesis of
thromboembolic complications in coronavirus disease 2019 (COVID-19). We isolated …

High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial

C Crimi, A Noto, F Madotto, M Ippolito, S Nolasco… - Thorax, 2023 - thorax.bmj.com
Rationale In patients with COVID-19 pneumonia and mild hypoxaemia, the clinical benefit of
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …

Airway pressure release ventilation for acute respiratory failure due to coronavirus disease 2019: A systematic review and meta-analysis

A Roshdy, AS Elsayed… - Journal of Intensive Care …, 2023 - journals.sagepub.com
Objective: To explore the evidence surrounding the use of Airway Pressure Release
Ventilation (APRV) in patients with coronavirus disease 2019 (COVID-19). Methods: A …

Update on the management of acute respiratory failure using non-invasive ventilation and pulse oximetry

T Abe, T Takagi, T Fujii - Annual Update in Intensive Care and Emergency …, 2023 - Springer
Abstract The coronavirus disease 2019 (COVID-19) pandemic has been the biggest
challenge to intensive care globally since the ventilator was invented to support patients with …

Use of high-flow nasal cannula oxygen and risk factors for high-flow nasal cannula oxygen failure in critically-ill patients with COVID-19

Z Ait Hamou, N Levy, J Charpentier, JP Mira… - Respiratory …, 2022 - Springer
Background High-flow nasal oxygen therapy (HFNC) may be an attractive first-line
ventilatory support in COVID-19 patients. However, HNFC use for the management of …

Mental disorders, COVID-19-related life-saving measures and mortality in France: A nationwide cohort study

M Schwarzinger, S Luchini, M Teschl, F Alla… - PLoS …, 2023 - journals.plos.org
Background Meta-analyses have shown that preexisting mental disorders may increase
serious Coronavirus Disease 2019 (COVID-19) outcomes, especially mortality. However …

Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective …

LF Reyes, S Murthy, E Garcia-Gallo, L Merson… - Critical care, 2022 - Springer
Background Up to 30% of hospitalised patients with COVID-19 require advanced respiratory
support, including high-flow nasal cannulas (HFNC), non-invasive mechanical ventilation …

Effect of non-invasive ventilation after extubation in critically ill patients with obesity in France: a multicentre, unblinded, pragmatic randomised clinical trial

A De Jong, A Bignon, F Stephan, T Godet… - The Lancet …, 2023 - thelancet.com
Background Non-invasive ventilation (NIV) and oxygen therapy (high-flow nasal oxygen
[HFNO] or standard oxygen) following extubation have never been compared in critically ill …

[HTML][HTML] The global, regional, and national burden and trends of NAFLD in 204 countries and territories: an analysis from global burden of disease 2019

H Chen, Y Zhan, J Zhang, S Cheng… - JMIR Public Health …, 2022 - publichealth.jmir.org
Background Nonalcoholic fatty liver disease (NAFLD) poses a substantial socioeconomic
burden and is becoming the fastest growing driver of chronic liver disease, potentially …